Dentistry Driven

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

us-based-data-show-astrazenecas-covid-19-vaccine-effective

US-Based Data Show AstraZeneca’s COVID-19 Vaccine Is Effective

Dimensions of Dental Hygiene

MARCH 22, 2021

Results recently culled from a large clinical trial conducted in the United States show that the COVID-19 vaccine created in partnership by AstraZeneca and the University of Oxford is 79% effective at preventing COVID-19 illness, and no significant side effects were found among trial participants.

Early Data Show AstraZeneca COVID-19 Vaccine Is Effective Against UK Variant

Dimensions of Dental Hygiene

FEBRUARY 6, 2021

Developed in the United Kingdom, the COVID-19 vaccine from AstraZeneca and the University of Oxford has shown 74.6% effectiveness against the new, more contagious UK-based variant, B117, of SARS-CoV-2. The data from this study are expected in March. Click here to read more.

US-Based Data Show AstraZeneca’s COVID-19 Vaccine Is Effective

Early Data Show AstraZeneca COVID-19 Vaccine Is Effective Against UK Variant

Stay Connected